BioNexus Gene Lab Corp. - SIC # 5169 - CHEMICALS AND ALLIED PRODUCTS, NOT ELSEWHERE CLASSIFIED

Ticker Exchange SIC # Website Latest Ticker
BGLC Nasdaq 5169 www.bionexusgenelab.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for BioNexus Gene Lab Corp.

BioNexus Gene Lab Corp. Announces Appointment of Dr. Muthu Meyyappan as Chief Commercial Officer of Fidelion Diagnostics to Lead Global Commercialization of the VitaGuard™ MRD Platform - Mar 11th, 2026 6:45 am
BioNexus Gene Lab Corp. Completes Chemrex Governance Restructuring; Appoints Matthew Barsing as Chairman - Feb 23rd, 2026 6:30 am
BioNexus Launches Regional Deployment of VitaGuard™ MRD Infrastructure; Positioned to Challenge Legacy Oncology Platforms Across ASEAN’s Multi-Billion Dollar Market - Jan 28th, 2026 7:00 am
BioNexus Gene Lab Corp. Completes Strategic Investment in Fidelion Diagnostics; Secures 15% Equity Stake in Global AI-Oncology Platform and Exclusive Southeast Asian Rights for VitaGuard™ - Dec 3rd, 2025 6:45 am
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Secures $500 Million Equity Facility From ARC Group International to Support Expansion of Precision Diagnostics, CDMO Operations, and Therapeutic Commercialization - Dec 2nd, 2025 6:05 am
BioNexus Gene Lab Corp. (Nasdaq: BGLC) and Fidelion Diagnostics Execute Exclusive Southeast Asia License for VitaGuard™ MRD Platform as Part of Strategic Alliance with Tongshu Gene - Dec 1st, 2025 6:00 am
BioNexus Gene Lab Corp. (Nasdaq: BGLC) Announces Strategic Agreements with Fidelion Diagnostics for Southeast Asia MRD Commercialization - Nov 12th, 2025 6:00 am
BioNexus Gene Lab Corp. Files $100 Million Shelf Registration and Establishes $20 Million At-the-Market Program to Advance Strategic Growth Opportunities - Nov 10th, 2025 6:00 am
Top Midday Gainers - Jul 30th, 2025 12:02 pm
BioNexus Gene Lab Corp. and Fidelion Diagnostics Announce Landmark Alliance—Touted as a new “DeepSeek Moment” in Precision Oncology - Jul 30th, 2025 6:00 am
Wall Street Set to Open Lower Wednesday as Jobs Data Misses Forecasts - Jul 2nd, 2025 7:13 am
US Futures Subdued as Investors Eye Key Employment Data - Jul 2nd, 2025 6:29 am